Divisas / GERN
GERN: Geron Corporation
1.40
USD
0.03
(2.10%)
El tipo de cambio de GERN de hoy ha cambiado un -2.10%. En este caso, el precio mínimo en el mercado ha alcanzado 1.39, mientras que el máximo ha alcanzado 1.44.
Siga la dinámica de la pareja de divisas Geron Corporation. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GERN News
- SpyGlass Pharma appoints Elizabeth O’Farrell to board of directors
- Geron: I Think We've Seen This Movie Before (NASDAQ:GERN)
- Geron (GERN) Q2 Revenue Jumps 5,477%
- Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
- Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket
- Geron earnings beat, revenue topped estimates
- Geron appoints Harout Semerjian as new CEO amid RYTELO expansion
- Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates
- Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges
- Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN)
- Geron showcases RYTELO benefits at oncology meetings
- Geron Corp stockholders approve equity plan amendments
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GERN Lawsuit Alert! Class Action Lawsuit Against Geron Corporation - TipRanks.com
- ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Mutual Fund:LMOIX)
- Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments (GERN)
- Biotech Stocks Q1 2025 Recap: Winners And Underperformers
- ROSEN, A LEADING LAW FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GERN
- ROSEN, A RANKED AND LEADING FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GERN
- Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN)
- Why Geron Stock Is Plummeting Today
- Dow Dips Over 100 Points; TJX Earnings Top Views - AppLovin (NASDAQ:APP), Enveric Biosciences (NASDAQ:ENVB)
Rango diario
1.39
1.44
Rango anual
1.09
4.83
- Cierres anteriores
- 1.43
- Open
- 1.44
- Bid
- 1.40
- Ask
- 1.70
- Low
- 1.39
- High
- 1.44
- Volumen
- 3.342 K
- Cambio diario
- -2.10%
- Cambio mensual
- 23.89%
- Cambio a 6 meses
- -23.91%
- Cambio anual
- -70.28%
30 agosto, sábado